Left Atrial Mechanical Function and Incident Ischemic Cerebrovascular Events Independent of AF: Insights From the MESA Study

Mohammadali Habibi, Mytra Zareian, Bharath Ambale Venkatesh, Sanaz Samiei, Masamichi Imai, Colin Wu, Lenore J Launer, Steven Shea, Rebecca F Gottesman, Susan R Heckbert, David A Bluemke, João A C Lima, Mohammadali Habibi, Mytra Zareian, Bharath Ambale Venkatesh, Sanaz Samiei, Masamichi Imai, Colin Wu, Lenore J Launer, Steven Shea, Rebecca F Gottesman, Susan R Heckbert, David A Bluemke, João A C Lima

Abstract

Objectives: This study sought to assess the association of baseline left atrial (LA) phasic function measured with cardia magnetic resonance (CMR) and incident ischemic cerebrovascular events (CVE).

Background: LA remodeling is a known predictor of atrial fibrillation (AF), which is a risk factor for ischemic CVE. Despite studies showing an association between LA remodeling and ischemic CVE, the association of LA mechanical function with ischemic CVE in a population free of known cardiovascular disease is not fully studied.

Methods: Phasic LA volumes; total, passive, and active LA emptying fractions (LAEF); and peak longitudinal LA strain were measured using feature-tracking CMR in 4,261 MESA (Multi-Ethnic Study of Atherosclerosis) participants (61 ± 10 years of age; 48% male). All individuals were free of clinical cardiovascular disease at baseline. Participants were followed for 11.6 ± 3.5 years for the diagnosis of incident ischemic CVE, defined as ischemic stroke or transient ischemic attack adjudicated by vascular neurologists.

Results: During the follow-up, 193 (1.26 per 1,000 person-years) ischemic CVE (134 ischemic strokes and 59 TIAs) occurred. Individuals with incident ischemic CVE had larger LA volumes and lower passive, active, and total LAEFs at baseline. In multivariate analysis adjusted for known CVE risk factors, left ventricular mass and interim AF, total LAEF was associated with incident ischemic CVE (hazard ratio [HR]: 0.85 per SD; 95% confidence interval [CI]: 0.74 to 0.98; p = 0.027). The unadjusted HR for the lowest tertile of total LAEF compared to the highest tertile was 2.0 (95% CI: 1.43 to 2.79; p < 0.001), and the adjusted HR was 1.47 (95% CI: 1.04 to 2.05; p = 0.031). Addition of total LAEF to known clinical risk factors of CVE and left ventricular mass resulted in an improved predictive accuracy (C statistic of 0.76 vs. 0.73, respectively; p = 0.039).

Conclusions: Reduced total LAEF was associated with incident ischemic CVE independent of known cerebrovascular risk factors and incident AF. Assessment of LA function may add further information in stratifying asymptomatic individuals at risk for ischemic stroke.

Keywords: atrial fibrillation; atrial function; cardiac magnetic resonance; ischemic stroke; left atrial remodeling.

Copyright © 2019. Published by Elsevier Inc.

Figures

FIGURE 1. Feature Tracking Derived Left Atrial…
FIGURE 1. Feature Tracking Derived Left Atrial Volume and Strain Curves
(Left) Changes in LA volume during cardiac cycle (ventricular systole and diastole). Maximum, pre-atrial contraction, and minimum LA volumes (points A, B, and C, respectively) were measured using LA volume curve. (Right) Changes in LA longitudinal strain during cardiac cycle. Point D indicates peak longitudinal strain. LA = left atrium.
FIGURE 2. Atrial Variables by Strata of…
FIGURE 2. Atrial Variables by Strata of Atrial Fibrillation and Stroke/TIA
Bars demonstrate the means of each measured atrial variable by strata of atrial fibrillation and ischemic cerebrovascular events. AF = atrial fibrillation; LA = left atrial; TIA = transient ischemic attack.
FIGURE 3. Total Left Atrial Emptying Fraction…
FIGURE 3. Total Left Atrial Emptying Fraction and Incident Ischemic Cerebrovascular Events
The plot demonstrates the results of a restricted cubic spline model. The pink area above and below the pink line indicates the 95% confidence interval.
FIGURE 4. Kaplan-Meier Event-Free Survival Curves
FIGURE 4. Kaplan-Meier Event-Free Survival Curves
Kaplan-Meier survival curves showing the event-free survival of participants based on tertiles of total left atrial emptying fraction. The first tertile includes participants with the highest total LAEF, and the third tertile includes participants with the lowest total LAEF. LAEF = left atrial emptying fraction.
FIGURE 5. Kaplan-Meier Event-Free Survival Curves in…
FIGURE 5. Kaplan-Meier Event-Free Survival Curves in Individuals With CHA2DS2-VASc Score ≤1
Kaplan-Meier survival curves show the event-free survival of participants based on tertiles of total left atrial emptying fraction. The first tertile includes participants with the highest total LAEF, and the third tertile includes participants with the lowest total LAEF. CHA2DS2-VASc = congestive heart failure, Hypertension, Age ≥75 years, Diabetes mellitus, Prior stroke, transient ischemic attack [TIA], or thromboembolism, Vascular disease, Age 65–74 years, Sex category [female]); other abbreviations as in Figure 4.
Central Illustration. Factors leading to LA Remolding…
Central Illustration. Factors leading to LA Remolding and Their Relationships to Ischemic Stroke
Shared risk factors results in mechanical, structural, and electrical LA remodeling. Electrical changes promote AF development which also worsens LA remodeling. Mechanical changes increase blood stasis and risk of thromboembolism.

References

    1. Habibi M, Samiei S, Ambale Venkatesh B, et al. Cardiac magnetic resonance-measured left atrial volume and function and incident atrial fibrillation: results from MESA (Multi-Ethnic Study of Atherosclerosis). Circ Cardiovasc Imaging 2016;9.
    1. Hoit BD. Left atrial size and function: role in prognosis. J Am coli Cardiol 2014;63:493–505.
    1. Goldberger JJ, Arora R, Green D, et al. Evaluating the atrial myopathy underlying atrial fibrillation: identifying the arrhythmogenic and thrombogenic substrate. Circulation 2015;132:278–91.
    1. Inoue YY, Alissa A, Khurram IM, et al. Quantitative tissue-tracking cardiac magnetic resonance (CMR) of left atrial deformation and the risk of stroke in patients with atrial fibrillation. J Am Heart Assoc 2015;4.
    1. Obokata M, Negishi K, Kurosawa K, et al. Left atrial strain provides incremental value for embolism risk stratification over CHA (2)DS (2)-VASc score and indicates prognostic impact in patients with atrial fibrillation. J Am Soc Echocardiogr 2014;27:709–16.
    1. Benjamin EJ, D’Agostino RB, Belanger AJ, Wolf PA, Levy D. Left atrial size and the risk of stroke and death. The Framingham heart study. Circulation 1995;92:835–41.
    1. Nagarajarao HS, Penman AD, Taylor HA, et al. The predictive value of left atrial size for incident ischemic stroke and all-cause mortality in African Americans: the Atherosclerosis Risk in Communities (ARIC) study. Stroke 2008;39:2701–6.
    1. Kamel H, Bartz TM, Longstreth WT Jr., et al. Association between left atrial abnormality on ECG and vascular brain injury on MRI in the Cardiovascular Health Study. Stroke 2015;46:711–6.
    1. Kamel H, O’Neal WT, Okin PM, Loehr LR, Alonso A, Soliman EZ. Electrocardiographic left atrial abnormality and stroke subtype in the atherosclerosis risk in communities study. Ann Neurol 2015;78:670–8.
    1. Kamel H, Soliman EZ, Heckbert SR, et al. P-wave morphology and the risk of incident ischemic stroke in the Multi-Ethnic Study of Atherosclerosis. Stroke 2014;45:2786–8.
    1. Kamel H, Bartz TM, Elkind MSV, et al. Atrial cardiopathy and the risk of ischemic stroke in the CHS (Cardiovascular Health Study). Stroke 2018;49:980–6.
    1. Bild DE, Bluemke DA, Burke GL, et al. Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol 2002;156:871–81.
    1. Natori S, Lai S, Finn JP, et al. Cardiovascular function in multi-ethnic study of atherosclerosis: normal values by age, sex, and ethnicity. AJR Am J Roentgenol 2006;186:S357–65.
    1. Zareian M, Ciuffo L, Habibi M, et al. Left atrial structure and functional quantitation using cardiovascular magnetic resonance and multimodality tissue tracking: validation and reproducibility assessment. J Cardiovasc Magn Reson 2015;17:52.
    1. Rodevan O, Bjornerheim R, Ljosland M, Maehle J, Smith HJ, lhlen H. Left atrial volumes assessed by three- and two-dimensional echocardiography compared to MRI estimates. Int J Cardiac Imaging 1999;15:397–410.
    1. Healey JS, Connolly SJ, Gold MR, et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 2012;366:120–9.
    1. Kamel H, Hunter M, Moon YP, et al. Electrocardiographic left atrial abnormality and risk of stroke: northern Manhattan study. Stroke 2015;46:3208–12.
    1. Di Tullio MR, Sacco RL, Sciacca RR, Homma S. Left atrial size and the risk of ischemic stroke in an ethnically mixed population. Stroke 1999;30:2019–24.
    1. Pierdomenico SD, Pierdomenico AM, Di Carlo S, Di Tommaso R, Cuccurullo F. Left atrial enlargement and risk of ischemic stroke in elderly treated hypertensive patients. Am J Hypertens 2014;27:1179–84.
    1. Bouzas-Mosquera A, Broullon FJ, AlvarezGarcia N, et al. Left atrial size and risk for all-cause mortality and ischemic stroke. CMAJ 2011;183:E657–64.
    1. Delgado V, Di Biase L, Leung M, et al. Structure and function of the left atrium and left atrial appendage: AF and stroke implications. J Am Coll Cardiol 2017;70:3157–72.
    1. Leong DP, Joyce E, Debonnaire P, et al. Left atrial dysfunction in the pathogenesis of cryptogenic stroke: novel insights from speckle-tracking echocardiography. J Am Soc Echocardiogr 2017;30:71–9.
    1. Shih JY, Tsai WC, Huang YY, et al. Association of decreased left atrial strain and strain rate with stroke in chronic atrial fibrillation. J Am Soc Echocardiogr 2011;24:513–9.
    1. Sanchis L, Montserrat S, Obach V, et al. Left atrial function is impaired in some patients with stroke of undetermined etiology: potential implications for evaluation and therapy. Rev Esp Cardiol (Engl Ed) 2016;69:650–6.
    1. Kim D, Shim CY, Hong GR, et al. Clinical implications and determinants of left atrial mechanical dysfunction in patients with stroke. Stroke 2016;47:1444–51.
    1. Wong JM, Welles CC, Azarbal F, Whooley MA, Schiller NB, Turakhia MP. Relation of left atrial dysfunction to ischemic stroke in patients with coronary heart disease (from the heart and soul study). Am J Cardiol 2014;113:1679–84.
    1. Hausfater P, Costedoat-Chalumeau N, Amoura Z, et al. AL cardiac amyloidosis and arterial thromboembolic events. Scand J Rheumatol 2005;34:315–9.
    1. Peng W, Li M, Li H, et al. Dysfunction of myosin light-chain 4 (MYL4) leads to heritable atrial cardiomyopathy with electrical, contractile, and structural components: evidence from genetically-engineered rats. J Am Heart Assoc 2017;6.
    1. Vaziri SM, Larson MG, Benjamin EJ, Levy D. Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham heart study. Circulation 1994;89:724–30.
    1. Brambatti M, Connolly SJ, Gold MR, et al. Temporal relationship between subclinical atrial fibrillation and embolic events. Circulation 2014;129:2094–9.
    1. Martin DT, Bersohn MM, Waldo AL, et al. Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices. Eur Heart J 2015;36:1660–8.
    1. Yaghi S, Moon YP, Mora-McLaughlin C, et al. Left atrial enlargement and stroke recurrence: the Northern Manhattan Stroke Study. Stroke 2015;46:1488–93.
    1. Russo C, Jin Z, Liu R, et al. LA volumes and reservoir function are associated with subclinical cerebrovascular disease: the CABL (Cardiovascular Abnormalities and Brain Lesions) study. J Am Coll Cardiol Img 2013;6:313–23.
    1. Kamel H, Okin PM, Elkind MS, ladecola C. Atrial fibrillation and mechanisms of stroke: time for a new model. Stroke 2016;47:895–900.
    1. Zhang Y, Zhang P, Mu Y, et al. The role of renin-angiotensin system blockade therapy in the prevention of atrial fibrillation: a meta-analysis of randomized controlled trials. Clin Pharmacol Ther 2010;88:521–31.
    1. Swedberg K, Zannad F, McMurray JJ, et al. Eplerenone and atrial fibrillation in mild systolic heart failure: results from the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization And Survival Study in Heart Failure) study. J Am Coll Cardiol 2012;59:1598–603.
    1. Wang Z, Zhang Y, Gao M, et al. Statin therapy for the prevention of atrial fibrillation: a meta-analysis of randomized controlled trials. Pharmacotherapy 2011;31:1051–62.
    1. Kamel H, Longstreth WT Jr., Tirschwell DL, et al. The AtRial cardiopathy and antithrombotic drugs in prevention after cryptogenic stroke randomized trial: rationale and methods. Int J Stroke 2018. 1747493018799981.
    1. Eikelboom JW, Connolly SJ, Bosch J, et al. Rivaroxaban with or without aspirin in stable cardiovascular disease. N Engl J Med 2017;377:1319–30.
    1. Kumagai K, Nakashima H, Urata H, Gondo N, Arakawa K, Saku K. Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation. J Am Coll Cardiol 2003;41:2197–204.
    1. Vardoulis O, Monney P, Bermano A, et al. Single breath-hold 3D measurement of left atrial volume using compressed sensing cardiovascular magnetic resonance and a non-model-based reconstruction approach. J Cardiovasc Magn Reson 2015;17:47.
    1. Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am soc Echocardiogr 2015;28:1–39 e14..
    1. Patton KK, Heckbert SR, Alonso A, et al. N-terminal pro-B-type natriuretic peptide as a predictor of incident atrial fibrillation in the Multi-Ethnic Study of Atherosclerosis: the effects of age, sex and ethnicity. Heart 2013;99:1832–6.
    1. Jensen PN, Johnson K, Floyd J, Heckbert SR, Carnahan R, Dublin S. A systematic review of validated methods for identifying atrial fibrillation using administrative data. Pharmacoepidemiol Drug Saf 2012;21 suppl 1:141–7.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere